Diffusion-weighted MR enterography for evaluating Crohn's disease: Effect of anti-peristaltic agent on the diagnosis of bowel inflammation.

MLA

Park, So, et al. “Diffusion-Weighted MR Enterography for Evaluating Crohn’s Disease: Effect of Anti-Peristaltic Agent on the Diagnosis of Bowel Inflammation.” European Radiology, vol. 27, no. 6, June 2017, pp. 2554–62. EBSCOhost, https://doi.org/10.1007/s00330-016-4609-7.

APA

Park, S., Huh, J., Park, S., Lee, S., Kim, A., Yang, S.-K., Park, S. H., Park, S. H., Lee, S. S., & Kim, A. Y. (2017). Diffusion-weighted MR enterography for evaluating Crohn’s disease: Effect of anti-peristaltic agent on the diagnosis of bowel inflammation. European Radiology, 27(6), 2554–2562. https://doi.org/10.1007/s00330-016-4609-7

Chicago

Park, So, Jimi Huh, Seong Park, Seung Lee, Ah Kim, Suk-Kyun Yang, So Hyun Park, Seong Ho Park, Seung Soo Lee, and Ah Young Kim. 2017. “Diffusion-Weighted MR Enterography for Evaluating Crohn’s Disease: Effect of Anti-Peristaltic Agent on the Diagnosis of Bowel Inflammation.” European Radiology 27 (6): 2554–62. doi:10.1007/s00330-016-4609-7.